The Government of the United States of America; as represented by the Secretary; Department of Health and Human Services
发明人:
申请号：
EP17155603.8
公开号：
EP3205352A1
申请日:
2003.04.25
申请国别(地区):
EP
年份:
2017
代理人:
摘要：
The invention relates to a dengue virus tetravalent vaccine containing a common 30 nucleotide deletion (Δ30) in the 3'-untranslated region of the genome of dengue virus serotypes 1, 2, 3, and 4, or antigenic chimeric dengue viruses of serotypes 1, 2, 3, and 4.
